Q3 2024 |
417 |
$213M |
+$8.72M |
-$12.8M |
-$4.11M |
JPM, ABBV, PEP, STLD, LMT
|
Restatement |
10/25/2024, 04:02 PM |
Q2 2024 |
448 |
$279M |
+$6.36M |
-$1.68M |
+$4.69M |
EPD, AVGO, JPM, STLD, DUK
|
13F-HR |
8/20/2024, 05:26 PM |
Q1 2024 |
448 |
$278M |
+$15.8M |
-$15.3M |
+$432K |
EPD, JPM, STLD, AVGO, PEP
|
13F-HR |
5/29/2024, 05:17 PM |
Q4 2023 |
466 |
$262M |
+$4.93M |
-$5.29M |
-$365K |
EPD, JPM, AVGO, STLD, DUK
|
13F-HR |
7/19/2024, 10:56 AM |
Q3 2023 |
484 |
$242M |
+$22M |
-$20.1M |
+$1.96M |
EPD, PEP, STLD, JPM, DUK
|
13F-HR |
7/19/2024, 10:52 AM |
Q1 2023 |
498 |
$249M |
+$16M |
-$13.4M |
+$2.59M |
EPD, STLD, PEP, ABBV, DUK
|
13F-HR |
7/19/2024, 10:30 AM |
Q4 2022 |
575 |
$247M |
$0 |
$0 |
|
ABBV, STLD, PEP, EPD, DUK
|
13F-HR |
7/19/2024, 10:36 AM |